ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2018 American Transplant Congress » Concurrent Session: Kidney Immunosuppression: General Considerations - 2

Date: Tuesday, June 5, 2018

Time: 4:30pm-6:00pm

Location: Room 6A

Session Type: Concurrent Session

Meeting: 2018 American Transplant Congress

4:30pm-4:42pm
Tacrolimus Pharmacokinetics (PK) at Low, Medium, and High Trough Levels in Patients Converted from Twice-Daily Immediate-Release Tacrolimus (TacBID) to Once-Daily Extended-Release Tacrolimus (LCPT)

P. Malvezzi,1 S. Bunnapradist,2 D. Stevens,3 M. Moten,3 A. Loh,3 S. Patel,3 L. Rostaing.1

4:42pm-4:54pm
Follow Up of Patients Treated with the IgG Endopeptidase (IdeS) for Desensitization and HLA Incompatible (HLAi) Kidney Transplantation

S. Jordan,1 J. Choi,1 E. Huang,1 R. Najjar,1 A. Peng,1 X. Zhang,1 S. Louie,1 M. Haas,2 S. Sethi,1 I. Kim,1 A. Vo.1

4:54pm-5:06pm
Efficacy and Safety of Bleselumab in Kidney Transplant Recipients: A Phase 2, Randomized, Open-Label Study

R. Harland,1 G. Klintmalm,2 S. Jensik,3 H. Yang,4 J. Bromberg,5 J. Holman,6 M. Anil Kumar,6 V. Santos,6 T. Larson,6 X. Wang.6

5:06pm-5:18pm
A Phase-I Clinical Trial of Donor-Derived MIC Cell Infusion for the Induction of Donor-Specific Hyporesponsiveness after Living Donor Kidney Transplantation (TOL-1 Study)

C. Morath,1 A. Schmitt,2 C. Kleist,3 V. Daniel,3 G. Opelz,3 C. Süsal,3 F. Fälble,1 C. Sommerer,1 L. Wang,2 M. Zeier,1 M. Schmitt,2 M. Schaier,1 P. Terness.3

5:18pm-5:30pm
RNA Expression Profiling of Renal Allografts in the Cynomolgus Monkey Identifies Tolerance

R. Smith,1 M. Matsunami,3 B. Adam,2 A. Rosales,1 T. Oura,3 A. Cosimi,3 T. Kawai,3 M. Mengel,2 R. Colvin.1

5:30pm-5:42pm
B Cell Reconstitution: 36-Month Analysis of Patients Post-Alemtuzumab Induction Followed by Belatacept-Based Immunosuppression

Q. Gao,1 A. Mehta,2 A. Guasch,2 A. Ghali,2 A. Kirk,1 H. Xu.1

5:42pm-5:54pm
Emergence of a Costimulation-Susceptible T Cell Repertoire Post-Alemtuzumab Induction

Q. Gao,1 A. Mehta,2 A. Guasch,2 L. Stempora,1 A. Kirk,1 H. Xu.1

« View all sessions from the 2018 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences